← Leaderboards
Cecilia Pilar Chung
Vanderbilt University
$5,082,849
Attributed
$5,082,849
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2013–23$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,082,849 · 3
VA$0 · 1
By mechanism
R01$4,552,097 · 2
K23$530,752 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Toxic Effect”
- George R Seage · Abt Associates, Inc.$224,114,540
- Peter C Adamson · National Childhood Cancer Foundation$126,756,857
- Gregory H Reaman · National Childhood Cancer Foundation$123,836,183
- Carol Nesel · Westat$116,355,411
- Mary M Horowitz · Medical College Of Wisconsin$90,165,506
- Barney Sparrow · Battelle Memorial Institute$88,494,220
Research focus
Toxic EffectHigh RiskPharmaceutical PreparationsDatabasesCohortPlayFaceCessation Of LifeReportingAdverse EffectsResearch PersonnelPharmacoepidemiologySide EffectAmericanDrug UsageCase StudyDrug ToxicityMedicineAffectCatecholaminesClinical TrialsCongestive Heart FailureAdrenergic AgentsCardiotoxicity
Grant awards (21)
Comparative Safety of Pain Medications$265,142
R01 · FY2023 · AR · contact PI
Cardiovascular Risk of Non-Opioid Pain Medications$0
I01 · FY2023 · VA · contact PI
Cardiovascular Risk of Non-Opioid Pain Medications$0
I01 · FY2023 · VA · contact PI
Comparative Safety of Pain Medications$465,227
R01 · FY2022 · AR · contact PI
A Personalized Medicine Approach to Improve the Prediction of Azathioprine Toxicity$235,870
R01 · FY2022 · GM · contact PI
A Personalized Medicine Approach to Improve the Prediction of Azathioprine Toxicity$168,161
R01 · FY2022 · GM · contact PI
Cardiovascular Risk of Non-Opioid Pain Medications$0
I01 · FY2022 · VA · contact PI
Comparative Safety of Pain Medications$456,190
R01 · FY2021 · AR · contact PI
A Personalized Medicine Approach to Improve the Prediction of Azathioprine Toxicity$424,307
R01 · FY2021 · GM · contact PI
Cardiovascular Risk of Non-Opioid Pain Medications$0
I01 · FY2021 · VA · contact PI
Comparative Safety of Pain Medications$546,643
R01 · FY2020 · AR · contact PI
A Personalized Medicine Approach to Improve the Prediction of Azathioprine Toxicity$410,067
R01 · FY2020 · GM · contact PI
Cardiovascular Risk of Non-Opioid Pain Medications$0
I01 · FY2020 · VA · contact PI
Comparative Safety of Pain Medications$544,338
R01 · FY2019 · AR · contact PI
A Personalized Medicine Approach to Improve the Prediction of Azathioprine Toxicity$517,650
R01 · FY2019 · GM · contact PI
A Personalized Medicine Approach to Improve the Prediction of Azathioprine Toxicity$518,502
R01 · FY2018 · GM · contact PI
Drug-Drug Interactions and Preventable Adverse Events in Rheumatology$154,507
K23 · FY2016 · AR · contact PI
Drug-Drug Interactions and Preventable Adverse Events in Rheumatology$94,067
K23 · FY2015 · AR · contact PI
Drug-Drug Interactions and Preventable Adverse Events in Rheumatology$31,348
K23 · FY2015 · AR · contact PI
Drug-Drug Interactions and Preventable Adverse Events in Rheumatology$125,415
K23 · FY2014 · AR · contact PI
Drug-Drug Interactions and Preventable Adverse Events in Rheumatology$125,415
K23 · FY2013 · AR · contact PI